COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?

Bibliographic Details
Main Authors: Nicole F. Clark, Andrew W. Taylor-Robinson
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.620175/full
_version_ 1818575940974804992
author Nicole F. Clark
Nicole F. Clark
Andrew W. Taylor-Robinson
Andrew W. Taylor-Robinson
author_facet Nicole F. Clark
Nicole F. Clark
Andrew W. Taylor-Robinson
Andrew W. Taylor-Robinson
author_sort Nicole F. Clark
collection DOAJ
first_indexed 2024-12-15T00:47:43Z
format Article
id doaj.art-6b70996a1dff437d95cc9d32e8d639da
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-15T00:47:43Z
publishDate 2021-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-6b70996a1dff437d95cc9d32e8d639da2022-12-21T22:41:30ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2021-03-01810.3389/fmed.2021.620175620175COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?Nicole F. Clark0Nicole F. Clark1Andrew W. Taylor-Robinson2Andrew W. Taylor-Robinson3Institute for Applied Ecology, University of Canberra, Bruce, ACT, AustraliaCentre for Marine Bioproducts Development, College of Medicine and Public Health, Flinders University, Bedford Park, SA, AustraliaInfectious Diseases Research Group, School of Health, Medical and Applied Sciences, Central Queensland University, Brisbane, QLD, AustraliaCollege of Health and Human Sciences, Charles Darwin University, Casuarina, NT, Australiahttps://www.frontiersin.org/articles/10.3389/fmed.2021.620175/fullchlorophylltherapylymphopeniaSARS-CoV-2COVID-19coronavirus
spellingShingle Nicole F. Clark
Nicole F. Clark
Andrew W. Taylor-Robinson
Andrew W. Taylor-Robinson
COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
Frontiers in Medicine
chlorophyll
therapy
lymphopenia
SARS-CoV-2
COVID-19
coronavirus
title COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
title_full COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
title_fullStr COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
title_full_unstemmed COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
title_short COVID-19 Therapy: Could a Copper Derivative of Chlorophyll a Be Used to Treat Lymphopenia Associated With Severe Symptoms of SARS-CoV-2 Infection?
title_sort covid 19 therapy could a copper derivative of chlorophyll a be used to treat lymphopenia associated with severe symptoms of sars cov 2 infection
topic chlorophyll
therapy
lymphopenia
SARS-CoV-2
COVID-19
coronavirus
url https://www.frontiersin.org/articles/10.3389/fmed.2021.620175/full
work_keys_str_mv AT nicolefclark covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection
AT nicolefclark covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection
AT andrewwtaylorrobinson covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection
AT andrewwtaylorrobinson covid19therapycouldacopperderivativeofchlorophyllabeusedtotreatlymphopeniaassociatedwithseveresymptomsofsarscov2infection